Vimarsana
Biggest News Aggregation in the World

Page 19 - Twist Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Twist Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Twist Bioscience Today - Breaking & Trending Today

What Happens When an Artist's Technology Becomes Obsolete? - Vimarsana News

What Happens When an Artist's Technology Becomes Obsolete?

Curators and conservators are working to save — and update — art made with aging hardware.

16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood's Portfolio - Vimarsana News

16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood's Portfolio

In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood’s portfolio. To see more such companies, go directly to 5 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood’s Portfolio. Cathie Wood’s hedge […]

Source: yahoo.com
Baillie Gifford & Co. Has $25.98 Million Holdings in Twist Bioscience Co. (NASDAQ:TWST) - Vimarsana News

Baillie Gifford & Co. Has $25.98 Million Holdings in Twist Bioscience Co. (NASDAQ:TWST)

Baillie Gifford & Co. raised its position in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 17.6% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 1,269,926 shares of the company’s stock after acquiring an additional 189,896 shares during the period. Baillie Gifford & Co. owned approximately 2.22% […]

Source: wkrb13.com
Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapies - Vimarsana News

Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapies

Mana.bio's first-of-its-kind AI platform discovers and optimizes novel, customizable LNPs for tissue-specific delivery of nucleic acid-based therapeutics and vaccinesLed by a multidisciplinary team with expertise in drug delivery, nanotechnology, and

Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapies - Vimarsana News

Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapies

/PRNewswire/ -- Mana.bio, a biotechnology company accelerating programmable drug delivery, today unveiled its AI-based lipid nanoparticle (LNP) delivery...